India, March 24 -- Men who consistently skip prostate cancer screening appointments face a significantly higher risk of dying from the disease, according to new research identifying a high-risk group.
"Our study identifies that men who were invited for screening, but do not attend screening appointments are at significantly higher risk of dying from prostate cancer compared to men who were not offered screening or accepted an invitation for screening," said study's lead author, Renee Leenen, a Ph.D. researcher in the group of Professor Monique Roobol at the Erasmus MC Cancer Institute.
Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC), the world's largest prostate cancer screening study, were presented a...